Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro

Am J Obstet Gynecol. 1994 Jul;171(1):126-31. doi: 10.1016/0002-9378(94)90457-x.

Abstract

Objective: Our purpose was to study the capability of synthetic corticotropin-releasing hormone to directly stimulate human myometrium and to modulate the activity of prostaglandins F2 alpha and E2.

Study design: Strips from human myometrium were obtained from 127 elective cesarean sections at term. The in vitro effect of human rat corticotropin-releasing hormone on myometrial contractility has been studied in resting myometrial strips mounted in a two-chamber bath for isolated organs. Stimuli (corticotropin-releasing hormone, prostaglandins F2 alpha and E2, and oxytocin) were administered as one single dose in the perfusion chamber. In each experiment one myometrial strip was used as a control.

Results: Corticotropin-releasing hormone significantly increases (p < 0.01) the myometrial response to prostaglandin F2 alpha. The hormone neither has a direct inotropic effect nor is it able to enhance the effect of prostaglandin E2 and oxytocin on myometrial strips.

Conclusion: The positive effect of corticotropin-releasing hormone on the myometrial response to prostaglandin F2 alpha adds new support to the theory that placental corticotropins may modulate the onset of labor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Corticotropin-Releasing Hormone / physiology*
  • Dinoprost / physiology*
  • Dinoprostone / physiology
  • Female
  • Humans
  • In Vitro Techniques
  • Myometrium / physiology*

Substances

  • Corticotropin-Releasing Hormone
  • Dinoprost
  • Dinoprostone